RxDoctor Payments Data

Joseph Stenger, PA

Medical · Cincinnati, OHNPI 1558310094

Payments from drug & device makers

$2,152in general payments, 2019–2025

Across 115 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$453
  • AbbVie$371
  • Lilly USA, LLC$259
  • Pfizer$234
  • Merck$159
  • Amgen$104
  • plus $571 from 12 others

What the payments were for

  • Food & beverage$2,152100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,152 in reported general payments places this provider in the 80th percentile of 547 medical providers in Ohio.

See all medical providers in Ohio

Medicare billing

Part B allowed, 2024
$38,945
Medicare patients
301
Services billed
609

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban55$66,410
JardianceEmpagliflozin38$51,042
OzempicSemaglutide28$39,784
TrulicityDulaglutide24$39,186
MounjaroTirzepatide36$38,843
FarxigaDapagliflozin Propanediol19$21,599
JanuviaSitagliptin Phosphate13$17,108
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$11,405
Atorvastatin Calcium558$4,140
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$3,812
Arnuity ElliptaFluticasone Furoate15$3,366
Levothyroxine Sodium229$2,388
Omeprazole175$2,125
Fluticasone-SalmeterolFluticasone Propion/Salmeterol19$1,781
Losartan Potassium167$1,527

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$259$78,02860 claims
PfizerEliquis$234$66,41055 claims
Boehringer IngelheimJardiance$62$51,04238 claims
Novo NordiskOzempic$453$39,78428 claims
AstraZenecaFarxiga$56$21,59919 claims
MerckJanuvia$159$17,10813 claims
AbbVieSynthroid$371$1,36131 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 547 medical providers in Ohio.

Other medical in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →